Source and exploration of the peptides used to construct peptide-drug conjugates

European Journal of Medicinal Chemistry
2021.0

Abstract

Peptide-drug conjugates (PDCs) are a class of novel molecules widely designed and synthesized for delivering payload drugs. The peptide part plays a vital role in the whole molecule, because they determine the ability of the molecules to penetrate the membrane and target to the specific targets. Here, we introduce the source of different kinds of cell-penetrating peptides (CPPs) and cell-targeting peptides (CTPs) that have been used or could be used in constructing PDCs as well as their latest application in delivering drugs. What's more, the approaches of developing CPPs and CTPs and the techniques to discover novel peptides are focused on and summarized in the review. This review aims to help relevant researchers fast understand the research status of peptides in PDCs and carry forward the process of novel peptides discovery.

Knowledge Graph

Similar Paper

Source and exploration of the peptides used to construct peptide-drug conjugates
European Journal of Medicinal Chemistry 2021.0
Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment
European Journal of Medicinal Chemistry 2021.0
Development of potent CPP6–gemcitabine conjugates against human prostate cancer cell line (PC-3)
RSC Medicinal Chemistry 2020.0
Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin
Bioorganic & Medicinal Chemistry Letters 2006.0
Investigation on cellular uptake and pharmacodynamics of DOCK2-inhibitory peptides conjugated with cell-penetrating peptides
Bioorganic & Medicinal Chemistry 2017.0
Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides
Bioorganic & Medicinal Chemistry Letters 2017.0
A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery
Bioorganic & Medicinal Chemistry 2016.0
Conjugation of Paclitaxel to Hybrid Peptide Carrier and Biological Evaluation in Jurkat and A549 Cancer Cell Lines
ACS Medicinal Chemistry Letters 2017.0
Overcoming drug resistance by cell-penetrating peptide-mediated delivery of a doxorubicin dimer with high DNA-binding affinity
European Journal of Medicinal Chemistry 2017.0